Additionally, it has been demonstrated that in triple negative breast cancer cell lines, overexpression of PFN1 suppresses AKT (serine-threonine kinase) activation via upregulation of PTEN (phosphatase and tensin homolog) [99], indicating the tumor-suppressive character of PFN1 gene. The gene discussed is MARK2; the disease is triple-negative breast carcinoma.